BRAF and colorectal carcinoma: The studies on BRAF mutations beyond codon 600 in CRC are increasing; although their functional roles and clinical relevance have been discussed [9–11], the clinicopathologic features and prognoses of the CRC patients with rare BRAF mutations are unclear.